83% of Indian businesses see tech risks as a major threat: Report

83% of Indian businesses view technology advancements and the consequent rise is concerns around data privacy, security vulnerabilities, and regulatory compliance as major risk factors, according to Horizon Watch Emerging Risk Report 2024.

The report, published by Tata AIG General Insurance and Dun & Bradstreet India, was conducted among 300 business leaders across 25 sectors, including IT & ITeS, chemicals & pharmaceuticals, auto & auto-ancillary and financial services to identify emerging risks that Indian businesses will face over the next five years.

Also ReadIndian business focus more on ESG reporting and compliance than peers globally, reveals report

69% of respondents, which include corporates ranging from Tata Motors to ArcelorMittal Nippon Steel India, identified legal challenges as one of the leading contributors to emerging risks. “As regulatory landscapes grow increasingly complex, organisations are becoming more concerned about the potential impact of legal disputes on their operations and long-term strategies,” the report said. 

Also Read L&T secures significant order for its Hydrocarbon business What’s wrong with exit polls? In a first, Indian Railways operates 8 goods trains as long-haul trains in a single day to overcome crew shortage NPCI to develop UPI-like platform in Trinidad and Tobago

Environmental factors was another concern with 68% businesses rating this as an emerging risk with extreme weather conditions causing serious impediments to their supply chains. Regulatory changes (67% respondents) and geo-political instability (63%) were other major risks identified by Indian corporates.

Also ReadDeficits, debt and India’s growth prospects

Sushant Sarin, president – commercial business, TATA AIG General Insurance, said managing emerging risks is crucial to the sustainability and growth of any organisation and the report’s aim is to empower organisations to anticipate emerging challenges, mitigate risks, and ensure business continuity.

The report also highlighted that 51% of businesses are worried about evolving consumer preferences, driven by demographic shifts and the increasing demand for sustainable and digital-first solutions while 48% of businesses expressed concern over financial instability due to economic downturns, rising interest rates, and inflation, prompting companies to focus more on liquidity and risk management strategies.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth